2100% returns in a year: This small-cap pharma stock turned ₹10k into ₹18 lakh in 5 years

Remedium Lifecare Limited is involved in trading and selling various Advanced Pharmaceutical Intermediates (APIs) and other pharma products. To learn more about the company, visit the Remedium Lifecare website.

Market Cap₹1,107 Cr.
Current Price₹549
Intrinsic Value₹107
High / Low₹898 / ₹24.9
Stock P/E130
Industry PE52.8
Face Value₹5
PEG Ratio0.51
Promoters Holding1.11%
Pledged percentage0%
Debt₹1.18 Cr.
Debt to equity0.05
Cash Equivalents₹0.41 Cr.
Sales growth108%
Inventory₹39.3 Cr.
Current liabilities₹1,884 Cr.
Current assets₹1,906 Cr.
Remedium Lifecare Limited  - Pharmaceutical

Remedium Lifecare Limited Year-After-Year Performance

YearOpenCloseGain/ Fall

Remedium Lifecare has performed very well year after year. It showed a growth of over 112% in 2020, and 193% in 2021, and became a multibagger stock in 2023. In 2023 alone, it showed a growth of 1912% and multiplied its investors’ money 20 times.

Remedium Lifecare Limited Compound Performance

PeriodGrowthReturns on ₹10kCAGR
1 Year2096%₹2.1 Lakh2096%
2 Years2107%₹2.2 Lakh369%
3 Years5407%₹5.5 Lakh280%
4 Years15066%₹15 Lakh250%
5 Years18261%₹18 Lakh183%
MAX24300%₹24 Lakh165%
  • This stock has increased by 2096% in one year and by 2107% in the last 2 years.
  • The money of investors who had invested in it three years ago has increased 55 times.
  • For those who had invested Rs 10,000 in this stock four years ago, today the value of those Rs 10,000 shares has become Rs 15 lakh.
  • The stock has grown at a CAGR of 183% in the last five years.

Remedium Lifecare Profit & Loss

Figures in Rs. Crores

Profit & LossMar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Operating Profit0012812
OPM %-44%14%1%0%2%1%
Net Profit000159
EPS in Rs00.140.240.532.694.22

The company’s sales were quite good from the beginning but the company was not profitable. But in the last few years, it has also become profitable, which is expected to continue in the future also, that is why investors have bought heavily.

The company is almost debt-free and is expected to perform well in the coming quarter results. The company has recorded a good profit growth of 252% CAGR over the last 5 years, and an ROE of 44.6% over the last 3 years.

Remedium Lifecare Shareholding Pattern

Shareholding PatternJun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
No. of Shareholders6226046227051,7303,988

Promoters have continuously reduced their stake. Three years ago, promoter holding was 43.57%, which has now come down to 1.11% and public holding has increased to 98.81%.

Rate this post

Leave a Comment